BioDuro is Redefining CRDMO Partnerships With End-to-End Innovation

Armin Spura, PhD, CEO of BioDuro, talks about the company’s evolution into a fully integrated contract, research, and development manufacturing organization (CRDMO), offering seamless services across discovery to development and commercialization. Spura discusses recent expansions in commercial-scale API production, peptide scale-up, and high-potency capabilities at the company’s Bengbu, China location.

Watch this video and learn more about:

• What differentiates BioDuro as a high-touch, high-quality CRDMO and how its integrated model streamlines drug development.
• The company’s recent facility expansions in the U.S. and China in drug substance synthesis, peptide production, and more.
• How BioDuro navigates geopolitical and regulatory landscapes while scaling global operations and client-specific solutions.